Clinical Research into Orthotopic Homologous Heart Transplantation

ZHU Zhengyan,YAN Zhongya,WU Yijun,LU Zhong,LEI Hong,SUN Yun,ZHENG Li,WANG Hui,LI Jianan,SONG Xiaorong
DOI: https://doi.org/10.3969/j.issn.1007-5062.2006.02.008
2006-01-01
Abstract:Objective:To review the experience of orthotopic homologous heart transplantation in 3 cases, and to discuss some problems such as perioperative treatment, immunosuppressive therapy and preventing from infection etc. Method: Three cases of orthotopic homologous heart transplantation was performed from May 2004 to October 2004. All patients were performed with the procedure of the bicaval heart transplantation. Postoperative immunosuppressive drugs were cyclosporine + mycophenolate mofetil + prednisone. Result: 3 patients were discharged at 35 days after the heart transplantation. Their heart functions are normal in the follow_up of two to seven months. During the period of follow_up, all patients have no immunity rejection and pulmonary infection. Conclusion: Proper perioperative management, immunosuppressive therapy, preventing from infection are important factors for recovery at the early postoperative stage. These factors are strongly associated with survival rate of patients following heart transplantation.
What problem does this paper attempt to address?